61958-3401-1 : NDC 2026 Code

61958-3401-1 : Lenacapavir Sodium ( Yeztugo )

Additionally :

You can get information about “61958-3401-1” NDC code in 61958-3401-1 in HTML format

HTML | 61958-3401-1 in TXT (Plain Text) format

TXT | 61958-3401-1 in PDF (Portable Document Format)

PDF | 61958-3401-1 in XML format

XML formats.

NDC Code : 61958-3401-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "61958-3401-1",
    "PackageDescription": "4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3401-1) ",
    "NDC11Code": "61958-3401-01",
    "ProductNDC": "61958-3401",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Yeztugo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lenacapavir Sodium",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250618",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA220020",
    "LabelerName": "Gilead Sciences, Inc.",
    "SubstanceName": "LENACAPAVIR SODIUM",
    "StrengthNumber": "300",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HIV Capsid Inhibitors [MoA], Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-14",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250618",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}